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Atypical protein kinase C (PKC
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/
 

 
) is a convergent 
downstream target of the insulin-stimulated 
phosphatidylinositol 3-kinase and TC10 
signaling pathways
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nsulin stimulation of adipocytes resulted in the recruitment
of atypical PKC (PKC
 

 
/
 

 
) to plasma membrane lipid raft
microdomains. This redistribution of PKC
 

 
/
 

 
 was prevented
by 
 
Clostridium difficile
 
 toxin B and by cholesterol depletion,
but was unaffected by inhibition of phosphatidylinositol
(PI) 3-kinase activity. Expression of the constitutively active
GTP-bound form of TC10 (TC10Q/75L), but not the inactive
GDP-bound mutant (TC10/T31N), targeted PKC
 

 
/
 

 
 to the
plasma membrane through an indirect association with the
Par6–Par3 protein complex. In parallel, insulin stimulation
I
 
as well as TC10/Q75L resulted in the activation loop
phosphorylation of PKC
 

 
. Although PI 3-kinase activation
also resulted in PKC
 

 
/
 

 
 phosphorylation, it was not recruited
to the plasma membrane. Furthermore, insulin-induced
GSK-3
 

 
 phosphorylation was mediated by both PI 3-kinase–
PKB and the TC10–Par6–atypical PKC signaling pathways.
Together, these data demonstrate that PKC
 

 
/
 

 
 can serve as a
convergent downstream target for both the PI 3-kinase and
TC10 signaling pathways, but only the TC10 pathway induces
a spatially restricted targeting to the plasma membrane.
 
Introduction
 
TC10 is a member of the Rho family of small GTP-binding
proteins and has been recently identified as an important
proximal protein in the control of insulin action in adipocytes
(Chiang et al., 2001; Watson et al., 2001). This signaling
pathway appears to involve the insulin receptor–dependent
tyrosine phosphorylation of Cbl and its recruitment to lipid
raft microdomains through the adaptor proteins APS, Cbl-
associated protein (CAP), and flotillin (Baumann et al.,
2000; Liu et al., 2002). The tyrosine-phosphorylated Cbl can
form a ternary complex with the guanylnucleotide exchange
factor C3G through the small adaptor protein CrkII. Because
TC10 is constitutively localized to plasma membrane lipid
raft microdomains, the recruitment of C3G places it in close
proximity and results in the conversion of TC10 from the
inactive GDP-bound state to the active GTP-bound state
(Baumann et al., 2000; Chiang et al., 2001).
In vitro binding assays have indicated that active GTP-
bound TC10 can directly interact with a number of potential
effectors that were originally identified as binding proteins
for Cdc42 and/or Rac (Neudauer et al., 1998; Murphy et
al., 1999; Joberty et al., 2000; Lin et al., 2000). In mammalian
cells, over 20 potential effector-binding proteins have been
identified; however, the functional role of these in specific
cellular events appears to be highly dependent upon cell
context. For example, although expression of Cdc42 in
fibroblasts has marked effects on actin organization, there is
no significant change in the adipocyte actin cytoskeleton.
In contrast, TC10 expression results in a marked disruption
of adipocyte cortical actin organization, leading to an inhibition
of insulin-stimulated GLUT4 translocation (Chiang et al.,
2001; Kanzaki and Pessin, 2002; Kanzaki et al., 2002). Part
of this difference can be accounted for by the distinct spatial
compartmentalization of TC10 compared with Cdc42 and
other Rho family members. Unlike other Rho family proteins
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that undergo carboxyl-terminal geranylgeranylation, TC10
contains a CAAX sequence that specifies farnesylation and
dual palmitoylation responsible for targeting to plasma
membrane lipid raft microdomains (Watson et al., 2001).
Thus, the compartmentalization of these proteins implies
that functionally relevant downstream effectors must also
be spatially restricted to their appropriate sites of action.
In this regard, several reports have implicated atypical
PKCs (PKC
 

 
/
 

 
) as direct substrates for the phosphoinosi-
tide-dependent protein kinase 1 (PDK1). Insulin activates
PDK1 through the generation of phosphatidylinositol (PI)-
3,4,5P3 by the stimulation of the type 1A PI 3-kinase (Stan-
daert et al., 1997; Kotani et al., 1998; Bandyopadhyay et al.,
1999a). On the other hand, PKC
 

 
/
 

 
 has also been reported
to form a quaternary complex with Par6, Par3/ASIP, and ac-
tivated Cdc42 in various cell types (Joberty et al., 2000; Lin
et al., 2000; Noda et al., 2001). The Par proteins were origi-
nally identified as proteins involved in asymmetric cell divi-
sion and polarized growth in the 
 
Caenorhabditis elegans
 
 de-
velopment (Etemad-Moghadam et al., 1995; Watts et al.,
1996). Par6 is composed of a PDZ (PSD-95/Dlg/ZO-1) do-
main downstream of a motif that is similar to a Cdc42/Rac-
interacting binding (CRIB) domain, and both are appar-
ently required for the association of Par6 with Cdc42. In
addition, Par6 and atypical PKCs both contain PB1 (Phox and
Bem1) domains that are required for forming heterodimeric
complexes (Ponting et al., 2002). Par3, also termed ASIP,
contains three PDZ domains and specifically binds to both
Par6 and atypical PKCs at cell–cell contact sites in fibro-
blasts and epithelial cells (Izumi et al., 1998; Suzuki et al.,
2001). Thus, Par6 and Par3 proteins appear to provide scaf-
folding functions, linking atypical PKCs and the Rho family
small GTPases Cdc42 and Rac. Although it is not known
whether TC10 can form a similar signaling complex in vivo,
Figure 1. TC10 binds to PKC/ through the Par6–Par3 complex in 3T3L1 adipocytes. (A) 3T3L1 cells were allowed to reached confluency 
(d 0, lane 1) and were subjected to the adipocyte differentiation protocol for 4 (lane 2), 8 (lane 3), and 12 d (lane 4). Whole-cell detergent 
extracts were subjected to SDS-PAGE and immunoblotted with the indicated antibodies. (B) Differentiated adipocytes were electroporated 
with the cDNAs encoding for the empty vector (lane 1), the human Myc epitope-tagged wild-type TC10 protein (TC10/WT, lane 2), dominant-
negative TC10 (TC10/T31N, lane 3), and constitutively active TC10 (TC10/Q75L, lane 4) as described in the Materials and methods. 18 h later, 
whole-cell detergent extracts were prepared and immunoprecipitated with a Myc antibody and immunoblotted with indicated antibodies. 
These are representative immunoblots obtained in three independent experiments. (C) Adipocytes were electroporated with cDNAs encoding 
for PKC-EGFP plus empty vector (a–c) or the cDNA for the human Myc epitope-tagged TC10/T31N (d–f) or TC10/Q75L (g–i). 18 h later, the 
cells were serum starved, fixed, and subjected to confocal fluorescent microscopy. (D) Adipocytes were electroporated with cDNAs encoding 
HA-Par6B plus empty vector (a–c) or the cDNA for Myc-TC10/T31N (d–f) or Myc-TC10/Q75L (g–i). 18 h later, the cells were serum starved, 
fixed, and subjected to confocal fluorescent microscopy. Images are representative from three independent experiments.
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GTP-bound active TC10 has been reported to bind the
CRIB domain of Par6 using in vitro binding assays (Joberty
et al., 2000). Furthermore, it has been reported that overex-
pression of Par3 in adipocytes inhibits insulin-induced glu-
cose uptake and GLUT4 translocation (Kotani et al., 2000).
To reconcile the apparent role of PI 3-kinase signaling with
the scaffolding function of Par6–Par3, we have examined the
intracellular compartmentalization, Par6–Par3 interaction,
and phosphorylation of PKC
 

 
/
 

 
 in adipocytes. Our data
demonstrate that TC10 stimulates PKC
 

 
/
 

 
 phosphorylation
and recruitment to plasma membrane lipid raft micro-
domains in adipocytes through the Par6–Par3 complex. In
contrast, activation of PI 3-kinase signaling results in PKC
 

 
/
 

 
phosphorylation without detectable recruitment to the plasma
membrane. Importantly, insulin stimulation of adipocytes
results in an identical PKC
 

 
/
 

 
 localization as TC10 activa-
tion that is completely distinct from PI 3-kinase activation.
Furthermore, insulin-induced phosphorylation of GSK-3
 

 
appears to be mediated not only by the PI 3-kinase–PKB
pathway, but also by the TC10–Par6–atypical PKC signaling
pathway. Thus, PKC
 

 
/
 

 
 appears to function as a convergent
downstream target that can differentiate these two pathways
through restricted spatial compartmentalization.
 
Results
 
Activation of TC10 recruits PKC
 

 
/
 

 
 to the 
plasma membrane through the Par6–Par3 
complex in adipocytes
 
To determine whether TC10 can interact with the Par6–
Par3 complex and PKC
 

 
/
 

 
 in adipocytes, we initially exam-
ined the protein expression levels of Par3/ASIP and PKC
 

 
/
 

 
during adipocyte differentiation (Fig. 1 A). As previously re-
ported in several other cell types (Lin et al., 2000), three dif-
ferent isoforms of Par3 (180, 150, and 100 kD) were de-
tected in both 3T3L1 fibroblasts and fully differentiated
adipocytes (Fig. 1 A, lanes 1–4). There was no significant
change in either Par3 or PKC
 

 
/
 

 
 protein expression during
adipocyte differentiation, as there was a small but similar
parallel decrease in the 
 

 
-actin loading control.
Immunoprecipitation of an expressed myc epitope-tagged
wild-type TC10 protein (TC10/WT) resulted in the specific
coimmunoprecipitation of the 150-kD Par3 isoform as well
as PKC
 

 
/
 

 
 (Fig. 1 B, lanes 1 and 2). Consistent with this
finding, expression of a constitutively active TC10 mutant
(TC10/Q75L) resulted in a greater extent of Par3 and
PKC
 

 
/
 

 
 coimmunoprecipitation (Fig. 1 B, lane 4). In con-
trast, expression of an inactive TC10 mutant (TC10/T31N)
was unable to coimmunoprecipitate Par3 or PKC
 

 
/
 

 
 (Fig. 1
B, lane 3).
To confirm this observation in vivo, we coexpressed
PKC
 

 
-EGFP with either empty vector, TC10/T31N, or
TC10/Q75L in 3T3L1 adipocytes (Fig. 1 C). The expressed
PKC
 

 
-EGFP was primarily localized to the cytoplasm with
no evidence for any membrane association (Fig. 1 C, a–c).
As previously reported (Kanzaki and Pessin, 2001), the ex-
pressed TC10/T31N protein was predominantly localized
to the plasma membrane (Fig. 1 C, d–f). However, there was
no significant redistribution of PKC
 

 
-EGFP, which re-
mained predominantly cytosolic. TC10/Q75L was also pri-
marily concentrated at the plasma membrane, but in this
case there was a marked colocalization and recruitment of
PKC
 

 
-EGFP to the plasma membrane (Fig. 1 C, g–i). In
parallel, expression of Par6 resulted in a diffuse cytosolic dis-
tribution that was not significantly different when coex-
pressed with TC10/T31N (Fig. 1 D, a–f). In contrast, Par6
was recruited to the plasma membrane when coexpressed
with TC10/Q75L (Fig. 1 D, g–i).
In adipocytes, expression of the guanine nucleotide ex-
change factor C3G activates TC10 and potentiates the insulin
stimulation of GLUT4 translocation (Chiang et al., 2001).
Therefore, we activated the endogenous TC10 protein by
Figure 2. Expression of C3G or the constitutively 
active TC10 induces the recruitment of PKC to 
the plasma membrane. (A) 3T3L1 adipocytes were 
electroporated with the cDNAs encoding PKC-EGFP 
and Myc-C3G. 18 h later, the cells were serum starved, 
fixed, and subjected to confocal fluorescent micros-
copy for EGFP (a) and the Myc epitope-tagged TC10 
proteins (b). PKC-EGFP was recruited to the plasma 
membrane in the C3G-expressing cell (arrow), but 
not in the C3G-negative cell (arrowhead). This is a 
representative field of cells from 3–4 independent 
experiments. (B) 3T3L1 adipocytes were electroporated 
with cDNA encoding for Myc-TC10/Q75L (a–c) or 
Myc-C3G (d–f). 18 h later, the cells were serum starved, 
fixed, and subjected to confocal fluorescent micros-
copy for the expressed Myc-TC10/Q75L (a), Myc-C3G 
(d), and endogenous PKC/ (b and e) proteins. 
This is a representative field of cells from 3–4 
independent experiments.
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C3G overexpression and assessed the subsequent recruitment
of PKC
 

 
/
 

 
 (Fig. 2 A). In intact cells, the expressed PKC
 

 
-
EGFP protein was primarily cytosolic (Fig. 2 A, a–c; arrow-
head). However, upon coexpression with C3G there was a
marked redistribution of PKC
 

 
-EGFP to the plasma mem-
brane (Fig. 2 A, a–c; arrow). In addition, pretreatment of the
transfected adipocytes with the Rho-specific toxin 
 
Clostridium
difficile
 
 toxin B completely prevented the C3G-stimulated re-
cruitment of PKC
 

 
-EGFP (unpublished data).
To assess whether the endogenous adipocyte PKC
 

 
/
 

 
 is re-
cruited to the plasma membrane by TC10 activation, im-
munofluorescent localization of endogenous PKC
 

 
/
 

 
 was
performed in TC10/Q75L- and C3G-transfected 3T3L1
adipocytes (Fig. 2 B). Consistent with that observed with
overexpressed PKC
 

 
-EGFP, the endogenous PKC
 

 
/
 

 
 protein
was dispersed throughout the cells without any evidence for
membrane association in the nontransfected cells (Fig. 2 B, b
and c). In contrast, adipocytes expressing either TC10/Q75L
(Fig. 2 B, a–c) or C3G (Fig. 2 B, d–f) exhibited a clear plasma
membrane recruitment of the endogenous PKC
 

 
/
 

 
 protein.
Together, the data presented in Fig. 1 and Fig. 2 demonstrate
that TC10 activation (expressed and endogenous) results in
plasma membrane recruitment of the expressed or endoge-
nous PKC
 

 
/
 

 
 protein in adipocytes. Furthermore, these re-
sults establish an in vivo interaction between TC10 and the
ternary Par6–Par3–PKC
 

 
/
 

 
 protein complex.
 
Insulin stimulates plasma membrane recruitment 
of PKC
 

 
/
 

 
 and the Par6–Par3 complex through 
TC10 activation
 
Previous works have demonstrated that insulin stimulation re-
sults in the activation of TC10 (Chiang et al., 2001; Watson
et al., 2001). Therefore, to determine whether a physiological
agonist can also induce the plasma membrane recruitment of
the endogenous Par3 and PKC
 

 
/
 

 
 proteins, immunofluores-
cent localization was performed in basal and insulin-stimu-
lated adipocytes (Fig. 3). As previously observed, PKC
 

 
/
 

 
 was
distributed throughout the cells with no indication of com-
partmentalized localization at either low or high magnification
(Fig. 3 A, a and b). As expected, insulin stimulation resulted in
a distinct PKC
 

 
/
 

 
 translocation to the plasma membrane (Fig.
3 A, c and d). In parallel, Par3 was also distributed throughout
the cytosol in the basal state and underwent insulin-stimulated
translocation to the plasma membrane (Fig. 3 B, a–d).
In addition to the recently identified insulin-stimulated
CAP–Cbl–TC10 pathway, insulin is well established to acti-
vate PI 3-kinase–dependent signaling, resulting in the forma-
tion of PI3,4,5P3 and subsequent activation of PDK1 (Toker
and Newton, 2000; Cantley, 2002). Because PDK1 phosphor-
ylates and activates PKC
 

 
/
 

 
, we next compared the relative
contribution of TC10 and PI 3-kinase signaling in the plasma
Figure 3. Insulin stimulates recruitment of both the endogenous 
PKC/ and Par3 proteins to the plasma membrane. 3T3L1 adipocytes 
were serum starved and then incubated in the absence (a and b) or 
presence (c and d) of 100 nM insulin for 5 min. The cells were fixed 
and then subjected to immunostaining. (A) The endogenous PKC/ 
protein was labeled with a PKC/ antibody and Texas red–conjugated 
anti–rabbit IgG. (B) The endogenous Par3 protein was labeled with 
a Par3 antibody and Texas red–conjugated anti–rabbit IgG. The 
images in b and d were magnified 2.4 times compared with a and c. 
These are representative fields of cells from three independent 
experiments.
Figure 4. Insulin-induced PKC/ recruitment to the plasma 
membrane is PI 3-kinase–independent, but sensitive to toxin B 
and MCD. 3T3L1 adipocytes were serum starved and either left 
untreated (a and b) or incubated with 0.5 g/ml C. difficile toxin B 
(c), 100 nM wortmannin (Wort, d), or MCD (e) as described in the 
Materials and methods. The cells were then incubated in the absence 
(a) or presence (b–e) of 100 nM insulin for 5 min. Endogenous 
PKC/ was detected by confocal fluorescent microscopy using a 
PKC/ antibody and Texas red–conjugated anti–rabbit IgG. These 
are representative fields from 3–4 independent experiments.
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membrane recruitment of PKC/ (Fig. 4). As typically ob-
served, insulin stimulation resulted in the translocation of en-
dogenous PKC/ from the cytoplasm to the plasma mem-
brane (Fig. 4, a and b). Pretreatment of the adipocytes with
the Rho family C. difficile toxin B resulted in a complete inhi-
bition of the insulin-induced PKC/ recruitment (Fig. 4 c).
In contrast, pretreatment with the PI 3-kinase inhibitor
wortmannin had no significant effect on the insulin-
induced plasma membrane PKC/ recruitment (Fig. 4 d).
In addition, cholesterol depletion with methyl--cyclodextrin
(MCD) disperses proteins associated with plasma membrane
lipid raft microdomains and prevents insulin-stimulated
TC10 activation without affecting PI 3-kinase activation or PI
3-kinase–dependent downstream signaling (Watson et al.,
2001). Under these conditions, MCD also prevented the in-
sulin-stimulated plasma membrane recruitment of PKC/
(Fig. 4 e). Together, these data strongly suggest that the insu-
lin-induced recruitment of PKC/ to the plasma membrane
is primarily regulated by TC10 activation.
Insulin stimulates recruitment of PKC/ to 
caveolin-containing lipid raft microdomains
In adipocytes, TC10 is primarily localized to the large clus-
tered caveolin-containing cholesterol-enriched plasma mem-
brane lipid raft microdomains, and this spatial compartmen-
talization is necessary for TC10 activation and modulation
of GLUT4 translocation (Chiang et al., 2001; Watson et al.,
2001). Therefore, we analyzed the compartmentalization of
PKC/ and Par3 by nondetergent homogenization and su-
crose gradient fractionation (Fig. 5). As previously reported
(Baumann et al., 2000), caveolin was primarily found in the
low density regions of these gradients and was not affected
by insulin stimulation (Fig. 5 C, fractions 3 and 4). Al-
though a small amount of PKC/ was detected in the low
density fractions in the basal state, the majority of PKC/
was confined to the denser regions of the gradient (Fig. 5 A,
fractions 8–12). Insulin stimulation for 3 or 10 min resulted
in a significant increase in the amount of PKC/ that frac-
tionated in the low density fractions. Similarly, Par3 was ex-
clusively found in the high density fractions isolated from
cells in the basal state, whereas after insulin stimulation Par3
was recruited into the low density fractions (Fig. 5 B).
The recruitment of PKC/ to caveolin-enriched lipid raft
microdomains was further assessed by confocal immunofluo-
rescence microscopy of plasma membrane sheets (Fig. 6 A).
In adipocytes, caveolae are clustered into large 0.5–1.0-m
aggregates that can be readily visualized as ringlike structures.
TC10 appeared to be persistently localized to these structures
(Parpal et al., 2001; Watson et al., 2001; Kanzaki and Pessin,
2002). Immunofluorescence microscopy of isolated plasma
membrane sheets demonstrated the presence of these caveo-
lin-containing structures in both the basal and insulin-stimu-
lated adipocytes (Fig. 6 A, a and d). In the basal state, there
was a relatively low level of PKC/ associated with the iso-
lated plasma membrane sheet with no apparent colocaliza-
tion with caveolin (Fig. 6 A, b and c). In contrast, insulin
stimulation resulted in an increased amount of immunoreac-
tive PKC/ at the plasma membrane that was specifically
colocalized with the caveolin-positive ringlike structures (Fig.
6 A, e and f). Moreover, exogenously expressed Par6 was also
recruited to the Triton X-100 resistant membrane raft micro-
domains in response to insulin stimulation (Fig. 6 B). We in-
terpret these data to indicate that a portion of PKC/ and
Par6 that undergoes insulin-stimulated plasma membrane re-
cruitment is specifically targeted to the large organized caveo-
lin-positive plasma membrane microdomains that are also
the sites of TC10 localization.
Activation of the PI 3-kinase signaling pathway does not 
recruit PKC/ to the plasma membrane
It has been established that PKC/ is an important down-
stream effector for the PI 3-kinase in various cell types be-
cause the enzymatic activity of PKC/ is dependent on the
phosphorylation by PDK1, a target of the PI 3-kinase signal-
Figure 5. Insulin stimulates the redistribution of PKC/ and Par3 
by sucrose gradient fractionation. 3T3L1 adipocytes were serum 
starved and then incubated in the absence (0 min) or presence (3 and 
10 min) of 100 nM insulin. The cells were nondetergent homogenized, 
sonicated, and subjected to continuous sucrose gradient fraction-
ation as described in the Materials and methods. Fractions were 
then immunoblotted for the presence of PKC/ (A), Par3 (B), or 
caveolin 1 (C). These are representative immunoblots from three 
independent experiments. Fraction 1 is the top of the gradient 
(5% sucrose) and fraction 12 is the bottom gradient (35% sucrose).
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ing pathway (Chou et al., 1998; Le Good et al., 1998). To
examine a possible role of PI 3-kinase in the recruitment of
PKC/ in adipocytes, we took advantage of the membrane-
targeted catalytic subunit of PI 3-kinase (p110-CAAX) to se-
lectively induce PI 3-kinase–dependent responses (Fig. 7).
Previous analyses have demonstrated that the pleckstrin ho-
mology (PH) domain of Grp1 has a high affinity and selec-
tivity for PI3,4,5P3, and when expressed as a GFP fusion
protein, can be readily used to detect the production of this
lipid product (Kavran et al., 1998; Kanzaki et al., 2000). Ex-
pression of p110-CAAX resulted in the constitutive forma-
tion of PI3,4,5P3 as observed by the plasma membrane
localization of the coexpressed Grp1/PH-EGFP reporter fu-
sion construct (Fig. 7 a). This was specific to p110-CAAX
activity, as the localization of Grp1/PH-EGFP was com-
pletely abolished by wortmannin, but not by toxin B (Fig. 7,
b and c). Although expression of p110-CAAX resulted in
PI3,4,5P3 formation and PKB phosphorylation (unpub-
lished data), there was no significant recruitment of coex-
pressed PKC-EGFP to the plasma membrane (Fig. 7, d–f).
PKC/ is a convergent downstream target substrate for 
both TC10 and PI 3-kinase–dependent phosphorylation
It is well established that an enzymatic activity of PKC/
can be stimulated by phosphorylation of the activation loop
consensus threonine residue (Thr410 in PKC or Thr402 in
PKC) by PDK1 (Chou et al., 1998; Le Good et al., 1998).
Furthermore, several works have reported that insulin in-
duces the phosphorylation and activation of PKC/ in a PI
3-kinase–dependent manner in adipocytes (Kotani et al.,
1998; Bandyopadhyay et al., 1999b; Sajan et al., 1999;
Standaert et al., 1999, 2001). To investigate the relationship
between PKC/ recruitment by TC10 and that of PDK1-
dependent phosphorylation, we examined the phosphoryla-
tion state of the consensus threonine residue (Thr410) of
PKC-EGFP in 3T3L1 adipocytes coexpressing empty vec-
tor, TC10/Q75L, or p110CAAX (Fig. 8 A). As previously
reported (Kotani et al., 1998; Standaert et al., 2001), insulin
stimulation resulted in an approximate twofold increase in
the phosphorylation of PKC-EGFP (Fig. 8 A, lanes 1 and
2). Expression of p110CAAX resulted in a marked phos-
phorylation of PKC-EGFP in the absence of insulin stimu-
lation (Fig. 8 A, lane 3), with no additional effect of insulin
(Fig. 8 A, lane 4). Expression of TC10/Q75L, which caused
the recruitment of PKC-EGFP to the plasma membrane,
also resulted in the spontaneous phosphorylation of PKC-
EGFP in the basal state (Fig. 8 A, lane 5). The TC10/Q75L-
induced phosphorylation was not further augmented by in-
sulin stimulation (Fig. 8 A, lane 6). Furthermore, the PKC
phosphorylation induced by TC10/Q75L expression was
not inhibited by 100 nM wortmannin (Fig. 8 B, lanes 9 and
10), suggesting that basal activity of PDK1 and/or the pres-
ence of another PKC/ kinase is sufficient to phosphory-
late PKC as a consequence of membrane recruitment. A
similar phenomenon has also been observed for the plasma
membrane targeting of PKB by N-myristoylation (Kohn et
al., 1996). In any case, these data demonstrate that PKC
can be phosphorylated by both activation of PI 3-kinase sig-
naling and by TC10 recruitment to lipid raft microdomains.
To examine participation of the Par protein complex in
the TC10-mediated phosphorylation of PKC, wild-type
Par6B (WT), amino terminus (aa 1–154) deleted form
(N), carboxy terminus (aa 154–370) deleted form (C),
CRIB domain (131–140) deleted form (CRIB), or PB1
domain (D64A/D68A) points mutant form (DD/AA) of
Par6B were coexpressed with TC10/Q75L plus PKC-
EGFP, and the phosphorylation state of PKC-EGFP was
determined (Fig. 8 B). In control cells, there was a low basal
level of PKC phosphorylation that was reduced in cells ex-
pressing the dominant-interfering TC10 mutant TC10/
T31N (Fig. 8 B, lanes 1 and 2). Expression of TC10/Q75L
increased PKC phosphorylation, which was partially re-
duced by expression of Par6-WT, Par6-N, and Par6-C
(Fig. 8 B, lanes 3–6). Because Par6 functions as a scaffolding
protein, that small degree of inhibition probably reflects a
partial disruption of the appropriate stoichiometry of the
TC10–Par6–Par3–PKC complex. Importantly, the TC10/
Figure 6. Insulin stimulates the recruitment of endogenous PKC/ 
to the large organized caveolae-rosette structures in 3T3L1 adipocytes. 
(A) 3T3L1 adipocytes were serum starved and then incubated in the 
absence (a–c) or presence (d–f) of 100 nM insulin for 5 min. Plasma 
membrane sheets were prepared as described in the Materials and 
methods. The plasma membrane sheets were then subjected to 
confocal fluorescent microscopy using a caveolin 2 antibody 
(a and d) and a PKC/ antibody (b and e). Arrowheads indicate 
caveolin-rosette structures, and the merged images are shown in c 
and f. These are representative fields of the cells from three indepen-
dent experiments. (B) 3T3L1 adipocytes were electroporated with 
cDNA encoding for Myc-caveolin and Flag-Par6. 18 h later, the 
cells were serum starved and then incubated in the absence (a–c) 
or presence (d–f) of 100 nM insulin for 5 min. The cells were then 
treated for 5 min with ice-cold PBS containing 0.2% Triton X-100 
before fixation, and were imaged using the indicated antibodies.
Regulation of PKC/ by PI 3-kinase and TC10 | Kanzaki et al. 285
Q75L-mediated PKC phosphorylation was markedly re-
duced by coexpression of Par6-CRIB or Par6-DD/AA
(Fig. 8 B, lanes 7 and 8).
To confirm the functional role of Par6 in the insulin-
induced plasma membrane translocation of endogenous
PKC/, we next examined the effect of Par6-CRIB and
Par6-DD/AA by confocal fluorescent microscopy (Fig. 9).
As previously observed, insulin stimulation resulted in the
translocation of PKC/ in control nontransfected cells
(Fig. 9, b, c, e, and f; arrowheads). In contrast, cells express-
ing either Par6-CRIB or Par6-DD/AA failed to undergo
an insulin-induced translocation of endogenous PKC/
(Fig. 9, a–f; arrows). Similarly, endogenous PKC/ failed
to undergo insulin-stimulated plasma membrane transloca-
tion in cells expressing TC10/T31N (Fig. 9, g–i).
To examine the relative effect of these pathways on a
downstream target, we examined the phosphorylation of
GSK-3 (Fig. 10). Although serine 9 of GSK-3 is a well-
established substrate for PKB, several works have also re-
ported that this site is also a substrate for PKC isoforms
(Goode et al., 1992; Cook et al., 1996; Isagawa et al.,
2000). As expected, insulin treatment and expression of
p110CAAX resulted in the phosphorylation of GSK-3
(Fig. 10 A, lanes 1–4). Similarly, serine 9 phosphorylation of
GSK-3 also occurred by expression of TC10/Q75L (Fig.
10 A, lanes 5 and 6). As previously reported (Watson et al.,
2001), neither phosphorylation of PKB nor PI3,4,5P3 for-
mation was observed in the cells expressing TC10/Q75L
(unpublished data).
Inhibition of PI 3-kinase activity with wortmannin com-
pletely abolished insulin-stimulated PKB phosphorylation,
but only partially reduced GSK-3 phosphorylation (Fig. 10
B, lanes 3 and 4). Although toxin B itself slightly increased
basal GSK-3 phosphorylation, there was also a partial inhi-
bition of insulin-stimulated phosphorylation (Fig. 10 B,
Figure 7. Expression of p110-CAAX does not 
induce the recruitment of PKC/ to the plasma 
membrane. 3T3L1 adipocytes were electroporated 
with the cDNA encoding for p110-CAAX plus the 
cDNAs encoding either Grp1/PH-EGFP or PKC-
EGFP as described in the Materials and methods. 
18 h later, the cells were serum starved and were 
either untreated (a and d) or treated with 500 nM 
wortmannin (Wort, b and e) or 0.5 g/ml toxin B 
for 2 h (c and f). The subcellular localization of 
Grp1/PH-EGFP (a–c) and PKC-EGFP (d–f) was 
determined by confocal fluorescent microscopy. 
These are representative fields of the cell from 
3–4 independent experiments.
Par6-CRIB (lane 7), or Par6-DD/AA (lane 8). 18 h later, the cells 
were serum starved and were either left untreated (lanes 1–9) or 
incubated with 100 nM wortmannin (lane 10) for 30 min. PKC-EGFP 
was immunoprecipitated as described above, and the samples 
were immunoblotted with either antibodies against EGFP (bottom) 
or phospho-PKC/ (top). This is a representative blot from 3–4 
independent experiments.
Figure 8. TC10/Q75L, p110CAAX, and insulin stimulate the 
phosphorylation of PKC-EGFP on threonine 410 in 3T3L1 adipocytes. 
(A) 3T3L1 adipocytes were electroporated with the cDNA encoding 
for PKC-EGFP plus the cDNA encoding either the empty vector 
(lanes 1 and 2), p110-CAAX (lanes 3 and 4), or TC10/Q75L (lanes 5 
and 6). 18 h later, the cells were serum starved and then incubated 
in the absence (lanes 1, 3, and 5) or presence (lanes 2, 4, and 6) of 
100 nM insulin for 5 min. Cells were lysed in a buffer containing 
0.5% saponin plus 1% Triton X-100 as described in the Materials 
and methods. Whole-cell detergent extracts were immunoprecipitated 
with an EGFP antibody and immunoblotted with either antibodies 
against EGFP (bottom panels) or phospho-PKC/ (top panels). 
The intensity of each band detected by a phospho-PKC/–specific 
antibody was calculated by using NIH Image software. (B) 3T3L1 
adipocytes were electroporated with the cDNA encoding for 
PKC-EGFP plus the cDNA encoding either the empty vector 
(lane 1), TC10/T31N (lane 2), or TC10/Q75L (lanes 3–10) plus 
either Par6B-WT (lane 4), Par6-N (lane 5), Par6-C (lane 6), 
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lanes 5 and 6). More importantly, combined treatment with
both wortmannin and toxin B completely blocked insulin-
stimulated GSK-3 phosphorylation (Fig. 10 B, lanes 9 and
10). Furthermore, the inhibitory PKC pseudosubstrate
peptide also inhibited insulin-stimulated GSK-3 phos-
phorylation (Fig. 10 B, lanes 7 and 8). A combination of the
inhibitory PKC pseudosubstrate peptide and wortmannin
completely prevented insulin-stimulated GSK-3 phosphor-
ylation (Fig. 10 B, lanes 11 and 12). These results demon-
strate that in adipocytes, insulin stimulates serine 9 phos-
phorylation of GSK-3 through the activation of both
PKC/ and PKB.
Finally, we also examined the effect of dominant-interfer-
ing Par6 mutants and TC10/T31N on GSK-3 phosphory-
lation (Fig. 10 C). The insulin stimulation of GSK-3 phos-
phorylation was inhibited by expression of Par6-CRIB and
Par6-DD/AA (Fig. 10 C, lanes 1–6), but not by expression
of wild-type Par6 (Fig. 10 C, lanes 7 and 8). Similar to the
dominant-interfering Par6 mutants, expression of TC10/
T31N also inhibited insulin-stimulated GSK-3 phosphor-
ylation (Fig. 10 C, lanes 9 and 10). Together, these data
demonstrate that at least one pool of GSK-3 is phosphory-
lated by PKC/ through a mechanism requiring TC10 and
interactions with the Par6 protein complex.
Discussion
The atypical PKCs fall in the general category of the AGC
subfamily of protein kinases that includes PKB, serum- and
glucocorticoid-induced kinase, and p70S6 kinase (Toker
and Newton, 2000). The AGC subfamily of protein kinases
possesses two critical regulatory phosphorylation sites, the
first of which is a threonine residue that is phosphorylated
by PDK1 (Alessi et al., 1997, 1998; Stokoe et al., 1997;
Chou et al., 1998; Le Good et al., 1998; Pullen et al., 1998;
Frodin et al., 2002). In the case of PKC/, the first consen-
sus threonine residue (Thr410 in PKC and Thr402 in
PKC) is in the activation loop, whereas the second required
phosphorylation threonine/serine site in the carboxyl-termi-
nal tail is replaced by an acidic residue (Glu-579 in PKC
and Glu-573 in PKC; Chou et al., 1998; Le Good et al.,
1998; Balendran et al., 2000). Several works have dem-
onstrated that insulin activation of PDK1 (through PI
3-kinase) can directly phosphorylate the first activation loop
threonine, resulting in the stimulation of PKC/ catalytic
activity (Bandyopadhyay et al., 1999b; Standaert et al.,
1999). Furthermore, insulin-stimulated PKC/ activation
has been directly implicated in the translocation of GLUT4
and glucose uptake in adipocytes (Standaert et al., 1997; Ko-
tani et al., 1998; Bandyopadhyay et al., 1999b).
In this regard, recent evidence has demonstrated the pres-
ence of two distinct insulin signaling pathways that function
in concert to mediate GLUT4 translocation and glucose up-
take (Baumann et al., 2000; Chiang et al., 2001; Saltiel and
Kahn, 2001). One pathway occurs through the insulin stim-
ulation of IRS protein tyrosine phosphorylation, leading to
the association and activation of the type 1A PI 3-kinase
(Cheatham et al., 1994; Okada et al., 1994; Corvera and
Czech, 1998). The subsequent formation of PI3,4,5P3 re-
cruits other downstream signaling molecules such as PKB
and PDK1 to nonlipid raft regions of the plasma membrane
through their PH domains (Alessi et al., 1997; Stokoe et al.,
1997; Stephens et al., 1998). Although PKC/ does not
have a PH domain, PKC/ can associate with PDK1 and
accounts for the subsequent phosphorylation on the activa-
tion loop T410/T402 residues (Chou et al., 1998; Le Good
et al., 1998). More recently, a second pathway has been pro-
posed that results from the tyrosine phosphorylation of Cbl
and its recruitment to lipid raft microdomains through the
adaptor proteins APS and CAP (Ribon and Saltiel, 1997;
Baumann et al., 2000; Liu et al., 2002). In turn, tyrosine-
phosphorylated Cbl engages the CrkII–C3G complex that
Figure 9. Dominant-interfering Par6 mutants and 
TC10/T31N inhibit insulin-induced plasma membrane 
translocation of endogenous PKC/. 3T3L1 adipocytes 
were electroporated with cDNA encoding for HA-Par6-
CRIB (a–c), HA-Par6-DD/AA (d–f), or Myc-TC10/T31N 
(g–i). 18 h later, cells were serum starved and then 
incubated in the presence of 100 nM insulin for 5 min. 
Expressed HA-Par6 mutants and endogenous PKC/ 
were immunostained with antibodies against HA 
(a and d) and PKC/ (b and e). The cells expressing 
Myc-TC10/T31N were detected using the myc anti-
body. Arrows depict cells expressing the HA-Par6 and 
Myc-TC10/T31N mutants, and arrowheads indicate 
the cells not expressing HA-Par6 or myc-TC10. These 
are representative fields of cells from three independent 
experiments.
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recruits the C3G guanylnucleotide exchange activity to the
lipid raft microdomain regions where TC10 is also compart-
mentalized (Chiang et al., 2001; Watson et al., 2001, 2003).
The data presented in this report provide an important
connection between these pathways by demonstrating that
PKC/ is a convergent downstream target of both the IRS
PI 3-kinase and Cbl-TC10 signaling cascades. Because insu-
lin activates PDK1 and induces T410/T402 phosphoryla-
tion, it has been assumed that PKC/ is recruited to the
plasma membrane by PDK1 (Le Good et al., 1998; Balen-
dran et al., 2000). However, our data demonstrate that
TC10-dependent (and not PI 3-kinase–dependent) signals
are responsible for PKC/ plasma membrane localization,
at least in adipocytes. More precisely, the TC10-dependent
recruitment spatially restricts PKC/ to the large caveolin-
positive rosette structures in the plasma membrane of adipo-
cytes. However, this interaction directly results from the as-
sociation of the Par6–Par3–PKC/ complex with activated
TC10. This is consistent with the ability of TC10 to bind
Par6 in vitro. Similiarly, the highly homologous Rho family
member Cdc42 can also form a quaternary complex with
Par6, Par3, and atypical PKCs (Joberty et al., 2000). This
conclusion is further strengthened by the observation that
overexpression of Par3 inhibits insulin-stimulated PKC/
activation and GLUT4 translocation, presumably by dis-
rupting PKC/ phosphorylation and/or localization (Kot-
ani et al., 2000).
In addition to PKC/, PKB is also a downstream target of
the PI 3-kinase pathway and phosphorylates substrates with an
RXRXXS consensus motif (Lawlor and Alessi, 2001). Al-
though the substrate sites for PKC/-dependent phosphory-
lation are more degenerate (RXS, RXXS, or RXXSXR), they
share strong similarity to the PKB substrate recognition motif
(Nishikawa et al., 1997). Although serine 9 of GSK-3 is a
consensus PKB phosphorylation site, several reports directly
demonstrate that this site can also be phosphorylated by atypi-
cal PKCs (Ballou et al., 2001; Oriente et al., 2001). More re-
cently, scratch-induced migration in astrocytes resulted in
GSK-3 phosphorylation through a Cdc42–Par6–PKC sig-
naling cascade independent of PKB (Etienne-Manneville
and Hall, 2003). Although the physiological significance of
TC10–Par protein–PKC regulation of GSK-3 remains to
be determined, our data demonstrate that in adipocytes, GSK-
3 phosphorylation is controlled not only by PKB, but also by
Figure 10. PI 3-kinase and TC10 signaling pathways both 
contribute to GSK-3 phosphorylation through the activation 
of PKC/. (A) 3T3L1 adipocytes were electroporated with the 
cDNA encoding for either the empty vector (lanes 1 and 2), 
p110-CAAX (lanes 3 and 4), or TC10/Q75L (lanes 5 and 6). 
18 h later, the cells were serum starved and then incubated in 
the absence (lanes 1, 3, and 5) or presence (lanes 2, 4, and 6) 
of 100 nM insulin for 5 min. Whole-cell lysates were immuno-
blotted with either antibodies against phosphoserine 9 GSK-3 
(top panels) or GSK-3/ (bottom panels). (B) 3T3L1 adipocytes 
were serum starved and pretreated with 100 nM wortmannin 
for 10 min (lanes 3 and 4), 0.5 g/ml toxin B for 2 h (lanes 5 
and 6), 20 M myristoylated PKC pseudosubstrate for 1 h 
(lanes 7 and 8), 0.5 g/ml toxin B (2 h) plus 100 nM wortmannin 
(10 min; lanes 9 and 10), or 20 M myristoylated PKC pseudo-
substrate plus 100 nM wortmannin (10 min; lanes 11 and 12). 
The cells were then incubated with 100 nM insulin for 5 min. 
Whole-cell lysates were immunoblotted with either antibodies against phosphoserine 9 GSK-3 (top panels), GSK-3/ (middle panels), 
or phosphoserine 473-Akt (bottom panels). (C) 3T3L1 adipocytes were electroporated with 600 g cDNA encoding for the empty vector 
(lanes 1 and 2), Par6-CRIB (lanes 3 and 4), Par6-DD/AA (lanes 5 and 6), Par6-WT (lanes 7 and 8), or TC10/T31N (lanes 9 and 10). The 
serum-starved cells were incubated without (lanes 1, 3, 5, 7, and 9) or with (lanes 2, 4, 6, 8, and 10) 100 nM insulin for 5 min. Whole-cell 
lysates were subjected to immunoblotting by using either antibodies against phosphoserine 9 GSK-3 (top panels) or GSK-3/ (bottom panels). 
These are representative blots from three independent experiments.
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PKC/ through both TC10 and PI 3-kinase signals. Impor-
tantly, only the TC10 pathway results in the recruitment of
PKC/ to plasma membrane lipid raft microdomains.
Consistent with this idea, it is becoming increasingly ap-
parent that lipid raft microdomains play a central importance
in insulin action, including insulin-stimulated GLUT4 trans-
location. For example, multiple papers have demonstrated
that disruption of these structures using various pharmaco-
logical agents or a dominant-interfering caveolin mutant all
perturb insulin-stimulated GLUT4 translocation (Nystrom
et al., 1999; Watson et al., 2001). More recently, we have re-
ported that TC10 regulates a unique cortical actin structure
(caveolin-associated F-actin) in fully differentiated 3T3L1
adipocytes consisting of F-actin spikes emanating from inside
of the clustered caveolin-enriched rosette structures (Kanzaki
and Pessin, 2002). Together, the data presented in this paper
suggest an intriguing hypothesis that the caveolin-enriched
lipid raft microdomains might function as important signal-
ing platforms that orchestrate insulin signaling molecules in-
cluding PKC/. This hypothesis is also consistent with sev-
eral reports showing a functional role of atypical PKCs in
actin cytoskeleton regulation in other cell types (Gomez et
al., 1995; Coghlan et al., 2000).
In summary, the data presented in this paper demonstrate
that PKC/ serves as a convergent downstream target for
both the PI 3-kinase and TC10 signals, and can be phos-
phorylated once either of these pathways is activated. Nev-
ertheless, the spatial compartmentalization of PKC/ is
markedly different after activation of these pathways. More-
over, in fully differentiated adipocytes, insulin primarily re-
cruits PKC/ to the lipid raft microdomains and not to
ruffling/lamellipodia regions of the plasma membrane de-
spite coactivation of the PI 3-kinase pathway.
Materials and methods
Materials
C. difficile toxin B was obtained from TECHLAB. pcDNA3-C3G, pKH3-
TC10/T31N, and TC10/Q75L were prepared as described previously
(Chiang et al., 2001). pEGFP-PKC cDNA was purchased from CLON-
TECH Laboratories, Inc. The pCMV-Par6C cDNA and the Par3 antibody
were provided by Dr. Ian Macara (University of Virginia, Charlottesville,
VA). pKH3-Par6B-N (deletion of aa 1–154), Par6-C (deletion of aa 154–
370), Par6-CRIB (deletion of aa 131–140), and Par6-DD/AA (D64A/
D68A) were produced by the PCR-based method. The PKC/ antibody
was obtained from Santa Cruz Biotechnology, Inc. Antibodies against
GSK-3 phosphoserine-9 and PKB phosphothreonine-308 and phospho-
serine-473 antibodies were obtained from Cell Signaling Technology. The
phospho-specific PKC/ activation loop antibody (T410) was a gift of Dr.
Alex Toker (Harvard University, Boston, MA). The caveolin 1 and 2 anti-
bodies and the GSK-3/ antibody were purchased from Transduction
Laboratories, and the HA and Myc epitope tag antibodies were purchased
from Santa Cruz Biotechnology, Inc. Fluorescent secondary antibodies
were purchased from Jackson ImmunoResearch Laboratories and Molecu-
lar Probes, Inc. The myristoylated PKC pseudosubstrate was purchased
from Biosource International.
Cell culture and transient transfection of 3T3L1 adipocytes
Murine 3T3L1 preadipocytes were maintained, differentiated into adipo-
cytes, and transfected by electroporation as described previously (Thur-
mond et al., 1998). After electroporation, cells were plated on glass cover-
slips and allowed to recover in complete medium.
Immunofluorescence and image analysis
Transfected and intact adipocytes were washed in PBS and fixed for 20
min in 4% PFA/PBS. The cells were washed briefly in PBS, permeabilized
in PBS containing 0.1% saponin and 0.4% BSA for 10 min, and were then
blocked in 5% donkey serum (Sigma-Aldrich) for 1 h at RT. Primary and
secondary antibodies were used at 1:100 dilutions (unless otherwise indi-
cated) in 0.4% BSA/PBS, and samples were mounted on glass slides with
Vectashield® (Vector Laboratories). Cells were imaged using a confocal
fluorescence microscope (model LSM510; Carl Zeiss MicroImaging, Inc.).
Images were then imported into Adobe Photoshop® (Adobe Systems, Inc.)
for processing, and composite files were generated.
Preparation and processing of plasma membrane sheets
Adipocyte plasma membrane sheets were prepared as described previ-
ously (Kanzaki et al., 2000). In brief, cells were incubation with 0.5 mg/ml
poly-D-lysine for 1 min and then swollen in a hypotonic buffer (23 mM
KCl, 10 mM Hepes, 2 mM MgCl2, and 1 mM EDTA, pH 7.5) by three suc-
cessive rinses. The swollen cells were sonicated, and the bound plasma
membrane sheets were fixed with 2% PFA and blocked with 5% donkey
serum. The membrane sheets were then incubated with primary antibodies
for 90 min at RT. The primary antibodies were detected with Texas red–
conjugated donkey anti–mouse antibody and Alexa® 488–conjugated don-
key anti–rabbit antibody for 2 h at RT.
Immunoprecipitation and immunoblotting
After experimental treatments, the cells were solubilized in 50 mM Tris-
HCl, pH 7.4, 1% Triton X-100, 0.5% saponin, 150 mM NaCl, 2% glycerol,
5 mM sodium fluoride, 1 mM sodium vanadate, 1 mM sodium pyrophos-
phate, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml aprotinin, 5 g/ml
leupeptin, and 5 g/ml pepstatin A. The extracts were centrifuged at
13,000 g for 20 min to remove insoluble material, and 50 g total protein
was resolved by SDS-PAGE followed by immunoblotting and was visual-
ized with the SuperSignal® Chemiluminescence Detection kit (Pierce
Chemical Co.). For immunoprecipitation, whole-cell extracts were incu-
bated for 2 h at 4C with 5 g monoclonal myc antibody. The samples
were then precipitated with protein G PLUS-Sepharose (Santa Cruz Bio-
technology, Inc.) and immunoblotted as described above.
Nondetergent sucrose gradient fractionation
3T3L1 adipocytes were either left untreated or were treated with 100 nM
insulin for 3, 5, or 10 min. Cells were then washed with ice-cold PBS, rap-
idly scraped in 0.5 M sodium carbonate buffer (pH 11.0), and homoge-
nized on ice. The homogenates were then sonicated four times for 20 s
and combined with a buffer containing 25 mM MES (pH 6.5), 150 mM
NaCl, and 250 mM sodium carbonate plus 35% (wt/vol) sucrose. The sam-
ple was then loaded on a 5–35% continuous sucrose gradient and centri-
fuged at 39,000 rpm in a rotor (model SW41; Beckman Coulter) at 4C for
19 h.
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